![(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one](https://static.cymitquimica.com/products/3D/img/IZB32209.png "Click to enlarge")
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
CAS: 1233322-09-2
Ref. 3D-IZB32209
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one
Description:
(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-yl)prop-2-en-1-one is a novel anticancer drug that is currently undergoing clinical trials. It has been shown to induce autophagy and apoptosis in cancer cells and may be a potential treatment for various types of cancer. The mechanism by which (E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6,6'-dichloro)-2,4'-biphenylquinoline induces autophagy is not fully understood but may involve the following: (i) activation of AMP kinase via the mTOR pathway; (ii) induction of PGC1α expression; and (iii) inhibition of AKT phosphorylation.
Mesenchymal
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
425.9 g/mol
Formula:
C25H16ClN3O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
